{"text": ["Novo", "Nordisk\u2019s", "Long-Acting", "Insulins:", "A", "Performance", "Overview"], "created_at": "2018-08-13 18:55:02"}
{"text": ["Can", "Victoza", "Continue", "to", "Boost", "Novo", "Nordisk\u2019s", "Revenue", "Growth?"], "created_at": "2018-08-13 17:25:02"}
{"text": ["Novo", "Nordisk:", "A", "Financial", "Overview", "after", "the", "First", "Half", "of", "2018"], "created_at": "2018-08-13 15:50:28"}
{"text": ["The", "Zacks", "Analyst", "Blog", "Highlights:", "Novo", "Nordisk,", "J&J,", "Allergan,", "Editas,", "AstraZeneca,", "Merck", "and", "Bristol-Myers"], "created_at": "2018-08-13 13:08:18"}
{"text": ["The", "Zacks", "Analyst", "Blog", "Highlights:", "Novo", "Nordisk,", "J&J,", "Allergan,", "Editas,", "AstraZeneca,", "Merck", "and", "Bristol-Myers"], "created_at": "2018-08-13 13:08:18"}
{"text": ["The", "Zacks", "Analyst", "Blog", "Highlights:", "Novo", "Nordisk,", "J&J,", "Allergan,", "Editas,", "AstraZeneca,", "Merck", "and", "Bristol-Myers"], "created_at": "2018-08-13 11:38:11"}
